June 2, 2021, New York— JDRF, the leading global funder of type 1 diabetes (T1D) research, is set to host a panel and live Q&A session at the 14 th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) titled Moving Therapies Across the Type 1 Diabetes Disease Continuum and Across the Pipeline: The Critical Role in Public-Private Partnerships.
↧